Roche ’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)
Basel, 25 January 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review of a supplemental new drug application (sNDA) for the use of Evrysdi® (risdiplam) to treat pre-symptomatic babies under two months of age with spinal muscular atrophy (SMA). The sNDA submission incorporates interim data from the RAINBOWFISH study, which shows the majority of pre-symptomatic babies treated with Evrysdi achieved key milestones such as sitting, standing, walking and maintained the ability to swallow following 12 months of treatment. “Treating very youn...
Source: Roche Media News - January 25, 2022 Category: Pharmaceuticals Source Type: news
Roche ’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)
Basel, 25 January 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review of a supplemental new drug application (sNDA) for the use of Evrysdi® (risdiplam) to treat pre-symptomatic babies under two months of age with spinal muscular atrophy (SMA). The sNDA submission incorporates interim data from the RAINBOWFISH study, which shows the majority of pre-symptomatic babies treated with Evrysdi achieved key milestones such as sitting, standing, walking and maintained the ability to swallow following 12 months of treatment. “Treating very youn...
Source: Roche Investor Update - January 25, 2022 Category: Pharmaceuticals Source Type: news
Roche ’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under two months of age with spinal muscular atrophy (SMA)
Interim data submitted to the FDA show majority of pre-symptomatic babies treated withEvrysdi for at least one year were able to sit, stand and walk within timeframes typical of healthy babies, as well as maintain swallowingEvrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to dateBasel, 25 January 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review of a supplemental new drug application (sNDA) for the use of Evrysdi® (risdiplam) to treat pre-symptomatic babies under two months of age w...
Source: Roche Media News - January 25, 2022 Category: Pharmaceuticals Source Type: news
Roche ’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)
Interim data submitted to the FDA show majority of pre-symptomatic babies treated withEvrysdi for at least one year were able to sit, stand and walk within timeframes typical of healthy babies, as well as maintain swallowingEvrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to dateBasel, 25 January 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review of a supplemental new drug application (sNDA) for the use of Evrysdi® (risdiplam) to treat pre-symptomatic babies under two months of age w...
Source: Roche Investor Update - January 25, 2022 Category: Pharmaceuticals Source Type: news
Can You Treat Eczema and Psoriasis the Same Way?
Title: Can You Treat Eczema and Psoriasis the Same Way?Category: Diseases and ConditionsCreated: 1/3/2022 12:00:00 AMLast Editorial Review: 1/3/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - January 3, 2022 Category: Dermatology Source Type: news
What are Some Risk Factors for Hypoxic-Ischemic Encephalopathy Outcomes?
Discussion
“Neonatal encephalopathy, manifesting as altered responsiveness, seizures, apnea and abnormal muscle tone and reflexes, resulting from hypoxic-ischemic injury is termed hypoxic-ischemic encephalopathy (HIE).” Neonatal encephalopathy can be associated with other problems including stroke, hemorrhage, infection, pre-term brain injury and hypoglycemia as some examples. Sometimes more than one of these entities occurs simultaneously such as hypoglycemia and HIE. HIE can result in long-term neurological problems including motor, behavioral, and cognitive problems that can become apparent even years later....
Source: PediatricEducation.org - December 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Mayo Clinic Q & amp;A podcast: Got itchy, red skin?
When it comes to itchy, red skin, it ’s possible that psoriasis or atopic dermatitis, also known as eczema, could be the cause. "Psoriasis and eczema are both skin reactions to the inflammation or immune system coming to the skin and causing a reaction," says Dr. Dawn Davis, a Mayo Clinic dermatologist. Psoriasis is thought to be an immune system problem that causes the skin to regenerate at faster-than-normal rates. This rapid turnover of cells results… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 13, 2021 Category: Databases & Libraries Source Type: news
Atopic Dermatitis: Expert Shares Parents' Top Five Questions Atopic Dermatitis: Expert Shares Parents' Top Five Questions
Whether a child will outgrow eczema and the role of allergies are among the most common questions from parents.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 9, 2021 Category: Dermatology Tags: Dermatology News Source Type: news
Police called on Cree family trying to access care for baby in distress in northern Quebec
The Mukash family of Whapmagoostui, Que., say they received inadequate care and fell they faced discrimination from staff at the local Cree health board. They have filed a complaint with the board and are heading to Montreal to seek medical care for an 11-month-old baby with severe eczema and other health issues. (Source: CBC | Health)
Source: CBC | Health - November 18, 2021 Category: Consumer Health News Tags: News/Canada/North Source Type: news
How to treat baby eczema
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - November 5, 2021 Category: Consumer Health News Source Type: news
Featured review: What are the benefits and risks of visible light therapy for treating atopic eczema?
Cochrane Skin is pleased to announce the publication of a new review,Phototherapy for atopic eczema. This review was led by dermatologists from Amsterdam University Medical Centers, and supported by a key stakeholder: the American Academy of Dermatology (AAD). The AAD provided funding for this systematic review (32 studies, 1219 people with clinically diagnosed atopic eczema), which enabled publication of the protocol and full review within 13 months of title registration.Key messagesNarrowband (NB) ultraviolet B (UVB), compared to placebo (a sham treatment), may improve eczema severity (including itch) and may not affect ...
Source: Cochrane News and Events - November 4, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news
Featured review: What are the benefits and risks of light therapy for treating atopic eczema?
Cochrane Skin is pleased to announce the publication of a new review,Phototherapy for atopic eczema. This review was led by dermatologists from Amsterdam University Medical Centers, and supported by a key stakeholder: the American Academy of Dermatology (AAD). The AAD provided funding for this systematic review (32 studies, 1219 people with clinically diagnosed atopic eczema), which enabled publication of the protocol and full review within 13 months of title registration.Key messagesNarrowband (NB) ultraviolet B (UVB), compared to placebo (a sham treatment), may improve eczema severity (including itch) and may not affect ...
Source: Cochrane News and Events - November 4, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news
More Eczema in Children Exposed to Toxic Metals in Utero More Eczema in Children Exposed to Toxic Metals in Utero
Prenatal exposure to toxic metals is linked to much greater odds of atopic dermatitis by age 4, according to a Taiwan birth cohort study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news
Accidental ocular injury by topical dermatological agent: potassium permanganate (KMnO4) - Kandpal R, Gautam S.
Potassium permanganate (KMnO4) is a commonly used topical therapeutic agent in dermatology. It is readily available and widely used as a disinfectant and astringent. Due to its antiseptic and astringent properties, it is used for acute and sub-acute eczema... (Source: SafetyLit)
Source: SafetyLit - October 22, 2021 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
Connected skin therapy company Zerigo Health scores $43M
Zerigo Health, formerly Clarify Medical, makes a connected phototherapy device for skin conditions like psoriasis, vitiligo and eczema. (Source: mobihealthnews)
Source: mobihealthnews - October 21, 2021 Category: Information Technology Source Type: news
